EXEM Co (205100) Fair Value & Analysis
Technology · KR · Market cap 121B KRW
Fair value as of: Jun 24, 2026
Analysis
EXEM Co (205100) currently trades at 1,402 KRW, while our model-based Fair Value estimate is 1,828 KRW — implying the stock looks roughly 30.4% undervalued today. We read business quality at 80/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
EXEM Co., Ltd. operates as an IT performance management and big data platform company Korea and internationally. Its products include MaxGauge, a database performance management software; InterMax, a web application server DB integrated performance monitoring solution for application performance management; and CloudMOA, an integrated management solution of large-scale IT services in a hybrid cloud environment; XAIOps, an AI-based intelligent IT operation solution. The company offers EBIGs, a configuration, security, and operation solution; and KNIME a big data analysis solution. In addition, it provides DataSaker, an observability solution that monitors and analyzes software service development and operation. The company provides database, application, cloud, and diagnostics consulting services. EXEM Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is EXEM Co (205100) undervalued?
What is the fair value of 205100?
What is the quality score of 205100?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.